Skip to main content

azedra

azedra: developed by 1 company · 1 FDA decision.

azedra evidence translation

What we can confirm

What it means

Source-backed records connect azedra to PGNX; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could azedra → PGNX affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

iodine-based products

Study sponsors

No additional listed-company sponsor is linked.

Development Pipeline (1)
CompanyPhase
PROGENICS PHARMACEUTICALS INC (PGNX)
iodine-based products
Approved
FDA Decisions1 records
NDA209607Type 5 - New Formulation or New ManufacturerOrphan DrugPriorityIntravenousSolution

Frequently asked questions

Who is developing azedra?

azedra is being developed by PROGENICS PHARMACEUTICALS INC.

What is azedra's latest FDA decision?

The most recent tracked FDA decision for azedra is Approval, dated July 30, 2018.